Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2010 Mar;67(3):293-9.
doi: 10.1203/PDR.0b013e3181cb8e68.

Apolipoprotein E4 and sex affect neurobehavioral performance in primary school children

Affiliations
Comparative Study

Apolipoprotein E4 and sex affect neurobehavioral performance in primary school children

Summer F Acevedo et al. Pediatr Res. 2010 Mar.

Abstract

Apolipoprotein E4 (apoE4) and female sex are risk factors for developing Alzheimer's disease. It is unclear whether apoE4 contributes to behavioral function at younger ages. Standard neuropsychological assessments [intelligence quotient (IQ), attention, and executive function] and a test developed in this laboratory (Memory Island test of spatial learning and memory) were used to determine whether E4 and sex affect neuropsychological performance in healthy primary school children (age 7-10). A medical history was also obtained from the mother to determine whether negative birth outcomes were associated with apoE4. Mothers of apoE4+ children were more likely to report that their newborn was placed in an intensive care unit. A sex difference in birth weight was noted among apoE4- (males > females), but not apoE4+, offspring. Conversely, among apoE4+, but not apoE4- children, there was a sex difference in the Wechsler Abbreviated Scale of Intelligence (WASI) vocabulary score favoring boys. ApoE4- girls had better visual recall than apoE4+ girls or apoE4- boys on the Family Pictures test. Finally, apoE4+, unlike apoE4-, children did not show spatial memory retention during the Memory Island probe trial. Thus, apoE4 may affect neurobehavioral performance, particularly spatial memory, and antenatal health decades before any clinical expression of neurodegenerative processes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Screen shot of Memory Island during a visible trial. If the target (insert) is not reached in two-minutes, an arrow appears (shown).
Figure 2
Figure 2
Performance of apoE4- and apoE4+ children on the Immediate (A) and Delayed (B) Family Pictures tests. *p<.05, **p<.01, or §p<.001versus apoE4- females.
Figure 3
Figure 3
Speed (virtual units/sec) on the visible and hidden trials of Memory Island. ▲:males; ∇females. (*p<.05 versus males).
Figure 4
Figure 4
Spatial memory retention of apoE4- and apoE4+ children in the probe trial of Memory Island. *p<.05 versus other quadrants, ■: target, □: left, formula image: right, or formula image: opposite quadrant (for additional details, see text).

Similar articles

Cited by

References

    1. Herz J, Beffert U. Apolipoprotein E receptor: Linking brain development and Alzheimer's disease. Nat Rev Neurosci. 2000;1:51–58. - PubMed
    1. Mahley RW, Weisgraber KH, Innerarity TL, Rall SC., Jr Genetic defects in lipoprotein metabolism. Elevation of artherogenic lipoproteins caused by impaired catabolism. JAMA. 1991;265:78–83. - PubMed
    1. Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest. 1985;76:1501–1513. - PMC - PubMed
    1. Raber J, Wong D, Buttini M, Orth M, Bellosta S, Pitas RE, Mahley RW, Mucke L. Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. Proc Natl Acad Sci USA. 1998;95:10914–10919. - PMC - PubMed
    1. Shao Y, Gearing M, Mirra SS. Astrocyte-apolipoprotein E associations in senile plaques in Alzheimer disease and vascular lesions: a regional immunohistochemical study. J Neuropathol Exp Neurol. 1997;56:376–381. - PubMed

Publication types

MeSH terms

Substances